Todd Villines is a Cardiology physician affiliated with University of Virginia Health System. OpenAlex indexes 491 publications with 19,056 citations (h-index 68); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 Ray C Hunt Dr
Charlottesville, VA 229032981
Telephone
434-243-1000Provider last certified this registry record 22 Nov 2023.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- IDORSIA PHARMACEUTICALS US INCProgram year20252 payments
- HEARTFLOW, INC.Program year20256 payments
- Cleerly, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.9%Statin23.3%Rosuvastatin Calcium57%Atorvastatin Calcium43%Part D≥35 patientsBeta blocker20.2%Metoprolol Succinate75%Carvedilol16%Metoprolol Tartrate9%Part D<11 patients+ 9 more classes in this area
Blood & clotting
10.5%Factor Xa inhibitor8.4%Eliquis100%Part D≥18 patientsP2Y12 inhibitor2.1%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
10.5%SGLT2 inhibitor10.5%Jardiance100%Part D≥29 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Purow, MD
University of Virginia Health System
Linda Duska, MD
University of Virginia Health System
Kenneth Bilchick, MD
University of Virginia Health System
Mark Stoler, MD
University of Virginia Health System
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”